Metagenomi Therapeutics, Inc. Common Stock (MGX)

Typically moves ±6.24% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-13 APPROXIMATE

Metagenomi Therapeutics, Inc. Common Stock (MGX) has reported earnings 10 times since Mar 27, 2024. The stock moves an average of ±6.24% the day after reporting, closing higher 30.0% of the time. Its largest post-earnings gain was +3.83% (May 14, 2024) and its largest decline was -15.07% (Nov 12, 2025). The next earnings report is predicted for 2026-08-13 (approximate).

Earnings reactions

How MGX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.24%

Positive %

30.0%

Negative %

70.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 11, 2026	☽ POST	+0.37%	open_in_new
Mar 05, 2026	☽ POST	-7.19%	open_in_new
Nov 12, 2025	☀ PRE	-15.07%	open_in_new
Aug 12, 2025	☽ POST	+3.74%	open_in_new
May 13, 2025	☽ POST	-6.25%	open_in_new
Mar 17, 2025	☽ POST	-8.51%	open_in_new
Nov 13, 2024	☽ POST	-11.37%	open_in_new
Aug 14, 2024	☀ PRE	-4.31%	open_in_new
May 14, 2024	☽ POST	+3.83%	open_in_new
Mar 27, 2024	☀ PRE	-1.78%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.24%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 7 →

Funds holding

$884314

Total value held

Buying

3 added · 1 reduced

Blackrock, Inc.

$308379 +2.67%

Wells Fargo & Company/Mn

$270865 +70.71%

State Street Corp

$161372 Held

Northern Trust Corp

$100730 Held

Morgan Stanley

$36938 -53.81%

SEC Filing Types

Recent SEC Filings

8 most recent

Form	Date Filed	View on EDGAR
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
8-K	20260610	open_in_new SEC.gov

Frequently asked about MGX earnings

When does Metagenomi Therapeutics, Inc. Common Stock report earnings next? expand_more

Metagenomi Therapeutics, Inc. Common Stock (MGX)'s next earnings date is approximate for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does MGX stock move after earnings? expand_more

Over 10 reports, MGX has moved an average of ±6.24% the session after earnings, closing higher 30.0% of the time.

What was MGX's biggest post-earnings move? expand_more

MGX's largest post-earnings gain on record was +3.83% on May 14, 2024, and its largest decline was -15.07% on Nov 12, 2025.

Where can I find Metagenomi Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Metagenomi Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.